BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 836891)

  • 1. A dialysis procedure for loading erythrocytes with enzymes and lipids.
    Deloach J; Ihler G
    Biochim Biophys Acta; 1977 Jan; 496(1):136-45. PubMed ID: 836891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages.
    Das PK; Murray GJ; Gal AE; Barranger JA
    Exp Cell Res; 1987 Feb; 168(2):463-74. PubMed ID: 3803450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.
    Brady RO; Pentchev PG; Gal AE; Hibbert SR; Dekaban AS
    N Engl J Med; 1974 Nov; 291(19):989-93. PubMed ID: 4415565
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme loading of erythrocytes.
    Ihler GM; Glew RH; Schnure FW
    Proc Natl Acad Sci U S A; 1973 Sep; 70(9):2663-6. PubMed ID: 4354859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of glucocerebrosidase using a fluorescent analogue of glucocerebroside for the diagnosis of Gaucher disease.
    Midorikawa M; Okada S; Yutaka T; Yabuuchi H; Naoi M; Kiuchi K; Yagi K
    Biochem Int; 1985 Sep; 11(3):327-32. PubMed ID: 4062951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocytes as carriers for glucocerebrosidase.
    Ihler GM
    Prog Clin Biol Res; 1982; 95():655-67. PubMed ID: 7122642
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation.
    Beutler E; Dale GL; Guinto DE; Kuhl W
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4620-3. PubMed ID: 200923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher's disease, chronic adult type: a comparative study of glucocerebroside and methylumbelliferyl-glucopyranoside cleaving potency in leukocytes.
    Klibansky C; Hoffman J; Zaizov R; Matoth Y
    Biomedicine; 1974 Jan; 20(1):24-30. PubMed ID: 4842687
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of rates of hydrolysis of N-oleoyl and N-stearoyl glucocerebroside in patients with Gaucher's disease.
    Peters SP; Aquino L; Naccarato WF; Gilbertson JR; Diven WF; Glew RH
    Biochim Biophys Acta; 1979 Oct; 575(1):27-36. PubMed ID: 508779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro.
    Dale GL; Kuhl W; Beutler E
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):473-5. PubMed ID: 284362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory diagnosis of Gaucher's disease. Value of leukocyte beta-glucosidase determination].
    Turpin JC; Bauman N; Castaigne P
    Nouv Presse Med; 1972 Jun; 1(23):1579-81. PubMed ID: 5035886
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.
    Dale GL; Beutler E
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4672-4. PubMed ID: 1070017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal and cellular models of Gaucher's disease. I. Refractoriness of thio analogs of glucocerebroside to enzymatic hydrolysis.
    Quirk JM; Weis AL; Shapiro D; Brady RO
    Biotechnol Appl Biochem; 1986 Feb; 8(1):96-100. PubMed ID: 3828086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identity of 'acid' beta-glucosidase and glucocerebrosidase in human spleen.
    Ho MW
    Biochem J; 1973 Nov; 136(3):721-9. PubMed ID: 4780697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glutaraldehyde treatment on enzyme-loaded erythrocytes.
    Deloach J; Peters S; Pinkard O; Glew R; Ihler G
    Biochim Biophys Acta; 1977 Feb; 496(2):507-15. PubMed ID: 402162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures.
    Gery I; Zigler JS; Brady RO; Barranger JA
    J Clin Invest; 1981 Nov; 68(5):1182-9. PubMed ID: 6795230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
    Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP
    Nature; 1992 Jun; 357(6377):407-10. PubMed ID: 1594045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebroside storage in normal monocyte cultures.
    Hardy B; Teitelman-Weissman B; Chazan S; Neri A
    Biomed Pharmacother; 1987; 41(1):40-4. PubMed ID: 3607254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new group of glucocerebrosidase isozymes found in human white blood cells.
    Ginns EI; Brady RO; Stowens DW; Furbish FS; Barranger JA
    Biochem Biophys Res Commun; 1980 Dec; 97(3):1103-7. PubMed ID: 7470138
    [No Abstract]   [Full Text] [Related]  

  • 20. Crystallization and preliminary X-ray analysis of recombinant human acid beta-glucocerebrosidase, a treatment for Gaucher's disease.
    Roeber D; Achari A; Manavalan P; Edmunds T; Scott DL
    Acta Crystallogr D Biol Crystallogr; 2003 Feb; 59(Pt 2):343-4. PubMed ID: 12554947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.